ArticleInternational archives of occupational and environmental health2004
Factors influencing long-term survival in mesothelioma patients--results of the German mesothelioma register.
Article in International archives of occupational and environmental health, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 54 citations in OpenAlex.
- Long-term survival in peritoneal mesothelioma treated with 24 consecutive PIPACs.Pleura and peritoneum · 2025Article
- Laying the Foundation for a Mesothelioma Patient Registry: Development of Data Collection Tools.International journal of environmental research and public health · 2023Article
- Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration.Scientific reports · 2022Article
- Review
- Predicting survival in malignant pleural mesothelioma using routine clinical and laboratory characteristics.BMJ open respiratory research · 2021Article
- Gender Differences in Outcomes of Patients With Mesothelioma.American journal of clinical oncology · 2020Article
- Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors.BMJ open respiratory research · 2018Article
- Clinical staging of malignant pleural mesothelioma: current perspectives.Lung Cancer (Auckland, N.Z.) · 2017Review
- Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma.Oncology reports · 2015Article
- The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial.British journal of cancer · 2015Observational
- Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2014Article
- Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.Journal of thoracic disease · 2013Review
- [Regional treatment of malignant pleural mesothelioma: results from the tumor centre Regensburg].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2013Article
- Biomarkers and prognostic factors for mesothelioma.Annals of cardiothoracic surgery · 2012Article
- Factors that impact susceptibility to fiber-induced health effects.Journal of toxicology and environmental health. Part B, Critical reviews · 2011Article
- Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma.Pathology oncology research : POR · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Between 1987 and 2000, the German mesothelioma register recorded a total of 4,455 patients with malignant mesotheliomas. Survival times for 498 (11.2%) patients were available; 155 patients (study group, 3.5% of the total group) survived for more than 2 years and 343 patients (control group, 7.7% of the total group) survived for fewer than 24 months. Male patients were over-represented in both groups, with 13% of women in the study and 4.4% in the control group. The proportion of pleural mesotheliomas was more than 90% in both groups, with peritoneal cases comprising 6.5% in the study group and 3.2% in the control group. Histologically, the epithelioid subtype was represented in 58% of the study group, whereas the biphasic subtype predominated (67.6%) in the control group. Only 7% of tumours were of the sarcomatoid subtype. The average age of patients in the study group was 57.4 years, thus lower than in the control group (62.8 years). Lung dust analysis showed an increased pulmonary asbestos burden in 94% of all patients; significant differences between the study and control group were not observed. In the majority of the total group pleural effusions were the first symptoms. Therapeutic data were available in fewer than 40% of all cases. Surgical interventions were performed, partly in combination with radiation and chemotherapy and as alternative treatments. Significant deviations in survival time dependent on therapy applied could not be proved. By multivariate analysis (Cox proportional hazards regression model) favourable prognostic factors for long-term survival were epithelioid tumour subtype, comparatively young age (<60 years), and female gender ( P<0.05).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.